Viewing StudyNCT03727477



Ignite Creation Date: 2024-05-06 @ 12:18 PM
Last Modification Date: 2024-10-26 @ 12:57 PM
Study NCT ID: NCT03727477
Status: COMPLETED
Last Update Posted: 2023-05-24
First Post: 2018-10-29

Brief Title: Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Organization: Intergroupe Francophone de Cancerologie Thoracique

Organization Data

Organization: Intergroupe Francophone de Cancerologie Thoracique
Class: OTHER
Study ID: IFCT-1803
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Pfizer INDUSTRY